Monoclonal Antibody-conjugated Polyphosphoester-hyd-DOX Prodrug Nanoparticles for Targeted Chemotherapy of Liver Cancer Cells
- 1 November 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Chinese Journal of Polymer Science
- Vol. 39 (11), 1392-1402
- https://doi.org/10.1007/s10118-021-2582-3
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Mild Method for Succinimide Hydrolysis on ADCs: Impact on ADC Potency, Stability, Exposure, and EfficacyBioconjugate Chemistry, 2014
- A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapyChemical Communications, 2014
- Polyprodrug Amphiphiles: Hierarchical Assemblies for Shape-Regulated Cellular Internalization, Trafficking, and Drug DeliveryJournal of the American Chemical Society, 2013
- Synthesis and characterization of a new multifunctional polymeric prodrug paclitaxel–polyphosphoester–folic acid for targeted drug deliveryPolymer Chemistry, 2013
- Drug and plasmid DNA co-delivery nanocarriers based on abctype polypeptide hybrid miktoarm star copolymersChinese Journal of Polymer Science, 2013
- Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug DeliveryJournal of the American Chemical Society, 2010
- A History of Cancer ChemotherapyCancer Research, 2008
- Paul Ehrlich's magic bullet concept: 100 years of progressNature Reviews Cancer, 2008
- Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJournal of Controlled Release, 2007
- Chemotherapy and the war on cancerNature Reviews Cancer, 2005